David P. Nowotnik

2.8k total citations · 1 hit paper
48 papers, 2.2k citations indexed

About

David P. Nowotnik is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Organic Chemistry. According to data from OpenAlex, David P. Nowotnik has authored 48 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Radiology, Nuclear Medicine and Imaging, 14 papers in Molecular Biology and 12 papers in Organic Chemistry. Recurrent topics in David P. Nowotnik's work include Radiopharmaceutical Chemistry and Applications (22 papers), Nanoparticle-Based Drug Delivery (8 papers) and Medical Imaging Techniques and Applications (7 papers). David P. Nowotnik is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (22 papers), Nanoparticle-Based Drug Delivery (8 papers) and Medical Imaging Techniques and Applications (7 papers). David P. Nowotnik collaborates with scholars based in United States, United Kingdom and Germany. David P. Nowotnik's co-authors include R.D. Neirinckx, Lewis R. Canning, Esteban Cvitkovic, Kirsten J. McTavish, John Rice, John McEwan, Gregory Russell‐Jones, R.D. Pickett, Richard A. Holmes and Wynn A. Volkert and has published in prestigious journals such as Cancer, Advanced Drug Delivery Reviews and Brain Research.

In The Last Decade

David P. Nowotnik

48 papers receiving 2.1k citations

Hit Papers

Technetium-99m d,l-HM-PAO: a new radiopharmaceutical for ... 1987 2026 2000 2013 1987 100 200 300 400

Peers

David P. Nowotnik
Yearn Seong Choe South Korea
David L. Kukis United States
Robert J. Nickles United States
Gann Ting Taiwan
Zhanhong Wu United States
Charles J. Smith United States
Yun‐Sang Lee South Korea
Jeongsoo Yoo South Korea
Dae Hyuk Moon South Korea
Yearn Seong Choe South Korea
David P. Nowotnik
Citations per year, relative to David P. Nowotnik David P. Nowotnik (= 1×) peers Yearn Seong Choe

Countries citing papers authored by David P. Nowotnik

Since Specialization
Citations

This map shows the geographic impact of David P. Nowotnik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David P. Nowotnik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David P. Nowotnik more than expected).

Fields of papers citing papers by David P. Nowotnik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David P. Nowotnik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David P. Nowotnik. The network helps show where David P. Nowotnik may publish in the future.

Co-authorship network of co-authors of David P. Nowotnik

This figure shows the co-authorship network connecting the top 25 collaborators of David P. Nowotnik. A scholar is included among the top collaborators of David P. Nowotnik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David P. Nowotnik. David P. Nowotnik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Nowotnik, David P. & Esteban Cvitkovic. (2009). ProLindac™ (AP5346): A review of the development of an HPMA DACH platinum Polymer Therapeutic. Advanced Drug Delivery Reviews. 61(13). 1214–1219. 132 indexed citations
3.
Campone, Mario, Jeany M. Rademaker-Lakhai, Jaafar Bennouna, et al.. (2007). Phase I and pharmacokinetic trial of AP5346, a DACH–platinum–polymer conjugate, administered weekly for three out of every 4 weeks to advanced solid tumor patients. Cancer Chemotherapy and Pharmacology. 60(4). 523–533. 77 indexed citations
4.
Russell‐Jones, Gregory, Kirsten J. McTavish, John McEwan, John Rice, & David P. Nowotnik. (2004). Vitamin-mediated targeting as a potential mechanism to increase drug uptake by tumours. Journal of Inorganic Biochemistry. 98(10). 1625–1633. 326 indexed citations
5.
Lin, Xinjian, et al.. (2003). Improved targeting of platinum chemotherapeutics. European Journal of Cancer. 40(2). 291–297. 45 indexed citations
6.
Eberling, Jamie L., Krzysztof S. Bankiewicz, Phillip Pivirotto, et al.. (1999). Dopamine transporter loss and clinical changes in MPTP-lesioned primates. Brain Research. 832(1-2). 184–187. 19 indexed citations
7.
Nowotnik, David P., et al.. (1999). Development of dopamine transporter imaging agents for the diagnosis of Parkinson's disease. Drug News & Perspectives. 12(3). 137–137. 6 indexed citations
8.
Pirro, John, et al.. (1997). Delineation of the border zone of ischemic rabbit myocardium by a technetium-labeled nitroimidazole. Nuclear Medicine and Biology. 24(3). 201–207. 8 indexed citations
9.
Dang, Wenbin, et al.. (1996). Effects of GLIADEL® wafer initial molecular weight on the erosion of wafer and release of BCNU. Journal of Controlled Release. 42(1). 83–92. 64 indexed citations
10.
Ramalingam, Kondareddiar, et al.. (1995). BATO complexes derived from dimethoxy dioximes: Synthesis, characterization and biodistribution. Nuclear Medicine and Biology. 22(5). 625–634. 2 indexed citations
11.
12.
Ramalingam, K., Natarajan Raju, P. Nanjappan, et al.. (1994). The Synthesis and in vitro Evaluation of a 99mTechnetium-Nitroimidazole Complex Based on a Bis(amine-phenol) Ligand: Comparison to BMS-181321. Journal of Medicinal Chemistry. 37(24). 4155–4163. 15 indexed citations
13.
Linder, Keith E., et al.. (1993). Synthesis, characterization, and in vitro evaluation of nitroimidazole-BATO complexes: New technetium compounds designed for imaging hypoxic tissue. Bioconjugate Chemistry. 4(5). 326–333. 34 indexed citations
14.
Rosenspire, Karen C., et al.. (1992). Direct analysis of whole blood by internal surface reversed-phase chromatography: an examination of the binding and metabolism of technetium dioxime complexes. Journal of Chromatography B Biomedical Sciences and Applications. 574(1). 119–126. 4 indexed citations
15.
Jurisson, Silvia S., et al.. (1991). Chloro → hydroxy substitution on technetium BATO [TcCl(dioxime)3BR] complexes. International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology. 18(7). 735–744. 12 indexed citations
16.
Linder, Keith E., David P. Nowotnik, Mary F. Malley, et al.. (1991). Technetium labeling of monoclonal antibodies with functionalized BATOs. 1. TcCl(DMG)3PITC [phenyl isothiocyanate].. Bioconjugate Chemistry. 2(3). 160–170. 28 indexed citations
17.
Linder, Karen E., David P. Nowotnik, Kondareddiar Ramalingam, et al.. (1991). Technetium-labeling of monoclonal antibodies with functionalized BATOs: 2. TcCl(DMG)3CPITC (CPITC=carboxyphenylisothiocyanate) labeling of B72.3 and NP-4 whole antibodies and NP-4 F(ab')2. Bioconjugate Chemistry. 2(6). 407–414. 17 indexed citations
18.
Nowotnik, David P., et al.. (1987). Synthesis and biological studies of the [99mTc]tetrachloronitrosyltechnetium(II) anion—An alternative low valent technetium starting material. International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology. 14(6). 573–577. 1 indexed citations
19.
Nowotnik, David P., et al.. (1985). Technetium thiodiglycollic acid (99mTc-TDG). A new radiopharmaceutical with the potential for the assessment of renal function. European Journal of Nuclear Medicine and Molecular Imaging. 11(8). 285–289. 5 indexed citations
20.
Nowotnik, David P., et al.. (1976). Polycyclic fused amidines. Part III. An unexpected mode of cyclisation of 2-phenacylisoquinolinium bromide. Journal of the Chemical Society Perkin Transactions 1. 201–201. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026